Main Topic Area
All Topic Areas
1 - 10 of 981 more >>
Articles
1 - 1 of 1
- Antagon Injection Consumer Information
Antagon is used to inhibit premature ovulation in women undergoing fertility procedures. Women who have experienced a hypersensitivity reaction to gonadotropin-releasing hormone (GnRH) or any other GnRH-type drug. Women who suspect or know they are pregnant. A physician specializing in fertility treatment should prescribe Antagon. Before starting treatment with Antagon, pregnancy must be ruled out. General Precautions with Antagon: Patients with hypersensitivity to GnRH should be closely...
U.S. Food and Drug Administration
News
1 - 5 of 336 more >>
- Initiation Of Phase III Program Using Emisphere's Eligen(R) Technology For Oral Salmon Calcitonin
MedicalNewsToday - Wed, 28 Feb 2007 08:00 EST
- Injection Drug Use Fueling Spread Of HIV In Mauritius
MedicalNewsToday - Mon, 26 Feb 2007 09:00 EST
- FDA Approves Astellas' Vaprisol(R) For The Treatment Of Hypervolemic Hyponatremia
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- International Narcotics Control Board Hindering HIV/AIDS Control Efforts, Should Be Independently Reviewed, Report Says
MedicalNewsToday - Mon, 05 Mar 2007 12:00 EST
- More Frequent Participation In Needle-Exchange Programs Does Not Increase Risk Of HIV Infection, Study Says
MedicalNewsToday - Fri, 02 Mar 2007 06:00 EST
Clinical Trials
1 - 5 of 305 more >>
- Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
ClinicalTrials.gov Identifier: NCT00486434 - Recruiting
Osteoarthritis
- Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women (a Pilot Study)
ClinicalTrials.gov Identifier: NCT00372099 - Recruiting
Bone Microarchitecture
- A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
ClinicalTrials.gov Identifier: NCT00525798 - Recruiting
Osteoporosis
- Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents with Inflammatory Bowel Disease
ClinicalTrials.gov Identifier: NCT00114803 - Completed
Ulcerative Colitis; Crohn''s Disease
- Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs
ClinicalTrials.gov Identifier: NCT00444808 - Recruiting
Rib Fractures; Pain; Intranasal Calcitonin

Not Signed In -

